Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
07/2003
07/17/2003WO2003057689A1 Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them
07/17/2003WO2003057688A2 Oxo or oxy-pyridine compounds as 5-ht4 receptor modulators
07/17/2003WO2003057676A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists
07/17/2003WO2003057675A1 Processes for production of cyclic diamine compounds or salts thereof
07/17/2003WO2003057674A1 4-sulfide / sulfoxide / sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
07/17/2003WO2003057673A1 1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
07/17/2003WO2003057672A2 Tetrahydroquinoline analogues as muscarinic agonists
07/17/2003WO2003057671A1 Biaryl compound and use thereof
07/17/2003WO2003057669A1 Androgen receptor antagonists
07/17/2003WO2003057668A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use
07/17/2003WO2003057666A2 Inhibitors of dipeptidyl peptidase iv
07/17/2003WO2003057220A1 Cyclic urea derivatives with 5-ht2c receptor activity
07/17/2003WO2003057219A1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder
07/17/2003WO2003057213A2 Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor
07/17/2003WO2003057212A1 Polyamide derivatives possessing antibacterial, antifungal or antitumor activity
07/17/2003WO2003057165A2 COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF AMYLOID-β PEPTIDE-RELATED DISORDERS
07/17/2003WO2003057147A2 Useful aroyl pyrrole heteroaryl methanones and methanols
07/17/2003WO2003057144A2 Change inhibitors of dipeptidyl peptidase iv
07/17/2003WO2003039488A3 A method for treating inflammatory bowel disease
07/17/2003WO2003022809A3 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
07/17/2003WO2002055496A8 Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
07/17/2003WO2002055495A8 Aryl piperidine derivatives as inducers of ldl-receptor expression
07/17/2003WO2002006280A3 INHIBITORS OF FACTOR Xa
07/17/2003US20030135057 5-amino- and 5-thio- substituted; prepared from a methylenedithietane intermediate
07/17/2003US20030135045 Glycoprotein IIb/IIIa antagonists
07/17/2003US20030135044 Novel gamma secretase inhibitors
07/17/2003US20030135043 Novel synthesis and crystallization of piperazine ring-containing compounds
07/17/2003US20030134888 Substituted diaminopyrazoles; treating diseases, such as cancer, inflammatory disorders, restenosis, and cardiovascular disease. coatings for implantable medical devices, such as prostheses, artificial valves, etc.
07/17/2003US20030134876 Inhibiting TNF alpha
07/17/2003US20030134858 Treatment of inflammation associated disorders, such as arthritis, colon cancer, and Alzheimer's disease
07/17/2003US20030134857 Synergistic insecticide mixtures
07/17/2003US20030134853 Tetrazolyl- and carbamidosulfonyl-substituted 2-phenyl-1-cycloalkyl -benzimidazoles or -imidazo(4,5b)pyridines that inhibit the RNA-dependent RNA polymerase encoded by Hepatitis C
07/17/2003US20030134852 Halogen substituted tetracyclic tetrahydrofuran derivatives
07/17/2003US20030134850 Hydrazinyl and nitrogen oxide pyrazoles
07/17/2003US20030134848 Substituted 1-aza-2-imino-heterocycles and their use as nicotinic acetylcholin receptors activators
07/17/2003US20030134841 Succinoylamino lactams as inhibitors of A-beta protein production
07/17/2003US20030134840 Novel compounds
07/17/2003US20030134839 5-(Alkylidene-cycloalkyl)-and 5-(alkylidene-heterocyclyl)-pyrazoles
07/17/2003US20030134838 Treatment of illnesses in which beta -amyloid modulators have a therapeutic benefit, the use thereof for preparing a pharmaceutical composition with the abovementioned properties, and processes for the preparation thereof.
07/17/2003US20030134837 Pharmaceutically acceptable salts thereof; their use as inhibitors of Raf kinases and pharmaceutical compositions containing them and anticancer agents
07/17/2003US20030134836 Substituted arylamine derivatives and methods of use
07/17/2003US20030134827 Lactams or pharmaceutically acceptable salt forms thereof, wherein rings ring B is a 4-8 membered cyclic amide containing from 0-3 additional heteroatoms selected from N, O, and S, which are useful as metalloprotease inhibitors.
07/17/2003CA2472165A1 3,4-di-substituted pyridazinediones as cxc chemokine receptor antagonists
07/17/2003CA2471885A1 4-sulfide / sulfoxide / sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
07/17/2003CA2471880A1 1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
07/17/2003CA2471754A1 Androgen receptor antagonist
07/17/2003CA2471204A1 Inhibitors of dipeptidyl peptidase iv
07/16/2003EP1327631A2 Fused heterocyclic compounds, their production and use as angiotensin II antagonists
07/16/2003EP1327630A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
07/16/2003EP1327629A1 New 2-pyrimidinyloxy-n-aryl-benzylamine derivatives, their processes and uses
07/16/2003EP1326864A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
07/16/2003EP1326861A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
07/16/2003EP1326859A1 Quinazoline derivatives with anti-tumour activity
07/16/2003EP1326858A2 Piperidine compounds as anti-allergic
07/16/2003EP1326857A2 Diazacycloalkanedione derivatives which are useful as lfa-1 antagonists
07/16/2003EP1326856A1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
07/16/2003EP1326849A1 Benzodiazepine derivatives as inhibitors of gamma secretase
07/16/2003EP1326848A1 Dihydropyrimidine derivatives as cysteine protease inhibitors
07/16/2003EP1326843A1 Pyrazole derivatives for the treatment of viral diseases
07/16/2003EP1326841A1 Pyridinone derivatives for treatment of atherosclerosis
07/16/2003EP1326840A2 Substituted heterocyclic compounds for treating multidrug resistance
07/16/2003EP1326834A2 2-substituted heterocyclic compounds
07/16/2003EP1326833A2 Substituted heterocyclic compounds for treating multidrug resistance
07/16/2003EP1326831A1 Substituted fused pyrroleimines and pyrazoleimines
07/16/2003EP1326830A1 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
07/16/2003EP1326619A2 Pyrrolidine modulators of ccr5 chemokine receptor activity
07/16/2003EP1326612A1 Gatifloxacin pentahydrate
07/16/2003EP1326611A1 Aza- and polyaza-naphthalenyl-carboxamides useful as hiv integrase inhibitors
07/16/2003EP1326606A2 Ep4 receptor inhibitors to treat rheumatoid arthritis
07/16/2003EP1246809B1 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them
07/16/2003EP1224182B1 N-substituted 1-(butyrolactone)-isoquinolines for treating nervous disorders
07/16/2003EP1175416B1 Heteroaryl diazacycloalkanes, their preparation and use
07/16/2003EP1155000B1 2-aminopyridines containing fused ring substituents
07/16/2003EP1076558B1 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens
07/16/2003EP1028955B1 Pyrimidinone compounds and pharmaceutical compositions containing them
07/16/2003EP1017385B1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1
07/16/2003EP0787720B1 Pyridonecarboxylate derivative or salt thereof and antibacterial containing the same as active ingredient
07/16/2003EP0758328B1 Anti-cancer compounds containing cyclopentaquinazoline ring
07/16/2003CN1430617A Process for producing carbostyril derivative
07/16/2003CN1430611A 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists
07/16/2003CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/16/2003CN1430609A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/16/2003CN1430608A Substituted iminoazines
07/16/2003CN1430605A Process for synthesis of amine ethers from secondary amino oxides
07/16/2003CN1114604C Bicyclic aryl carboxamides and their therapeutic use
07/16/2003CN1114598C Aromatic compounds and pharmaceutical compositions containing them
07/16/2003CN1114594C D4 receptor selectivity piperazine derivatives
07/16/2003CN1114592C Crystalline forms of osanetant
07/16/2003CN1114591C Cyclic amide compounds
07/16/2003CN1114403C Vitronectin receptor antagonists
07/15/2003USRE38188 Ethylene derivatives and pesticides containing said derivatives
07/15/2003US6593474 Adrenergic blocking agents
07/15/2003US6593472 NK-1 receptor active amine oxide prodrugs
07/15/2003US6593357 Treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease.
07/15/2003US6593356 The present invention relates to the synthesis of a new class of indeno(1,2-c)pyrazol-4-ones of formula (I): that are potent inhibitors of the class of enzymes known as cyclin dependent kinases, which relate to the catalytic subunits cdk1-7 and the
07/15/2003US6593351 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use
07/15/2003US6593349 3-(heteroarylamino) indazole, 1,2-benzisothiazole, or 1,2-benzisoxazole derivatives of given formula; for treating nervous system disorders such as pain, anxiety and bipolar disorder
07/15/2003US6593347 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
07/15/2003US6593346 Substituted 3-(piperidin-1-ylmethyl)cyclopentylamines, useful as modulators of the chemokine receptors CCR-5 and/or CC R-3.
07/15/2003US6593344 These substances have especially high cytostatic activities and pronounced immunosuppressive properties which make them suitable for therapeutic treatment in broad tumor spectrum and autoimmune diseases
1 ... 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 ... 1080